Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial

Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No changes to study details or visible content.
    Difference
    0.1%
    Check dated 2026-04-16T10:33:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:34:26.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2. The change is a site-wide version label visible on the page footer.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:16.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new page revision tag v3.4.2 is added and a previous funding notice about government operating status is removed. No study content, results, eligibility criteria, enrollment numbers, or navigation elements are altered.
    Difference
    0.5%
    Check dated 2026-02-11T01:47:33.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and a version update to v3.4.1 were added; the previous version was v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T22:29:18.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Show glossary was added; metadata labels were updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data) with Revision: v3.4.0 to replace v3.3.4. These changes are editorial and UI-focused and do not modify study data, eligibility criteria, or core functionality.
    Difference
    0.2%
    Check dated 2026-01-27T21:32:27.000Z thumbnail image

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.